Home/Filings/4/0001213900-24-021961
4//SEC Filing

Mahal Jeetinder Singh 4

Accession 0001213900-24-021961

CIK 0001788028other

Filed

Mar 11, 8:00 PM ET

Accepted

Mar 12, 9:33 PM ET

Size

10.1 KB

Accession

0001213900-24-021961

Insider Transaction Report

Form 4
Period: 2024-03-12
Mahal Jeetinder Singh
Chief Operating Officer
Transactions
  • Exercise/Conversion

    Voting Common Stock

    2024-03-12$7.10/sh+900$6,39025,909 total
  • Sale

    Voting Common Stock

    2024-03-12$26.44/sh900$23,79225,009 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2024-03-12+90016,472 total
    Exercise: $7.10Exp: 2030-05-31Voting Common Stock (900 underlying)
Footnotes (5)
  • [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2023.
  • [F2]Effective on January 4, 2024, the Issuer conducted a reverse stock split of its voting common stock at a ratio of 1-for-10 (the "Reverse Split"). The number of shares reported herein reflects the number of shares after the Reverse Split.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.14 to $26.79, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
  • [F4]The exercise price of the option and number of shares subject to the option were adjusted as a result of the Reverse Split, and numbers reported herein reflect the exercise price and number of shares subject to the option after the Reverse Split.
  • [F5]25% of the original number of shares subject to the option vested on December 12, 2020, and 1/48th of the original number of shares subject to the option vested monthly thereafter.

Documents

1 file

Issuer

Jasper Therapeutics, Inc.

CIK 0001788028

Entity typeother

Related Parties

1
  • filerCIK 0001882877

Filing Metadata

Form type
4
Filed
Mar 11, 8:00 PM ET
Accepted
Mar 12, 9:33 PM ET
Size
10.1 KB